Ophthalmology Doctors in Walla Walla, WA Accepting Medicare

5 Ophthalmology doctors found. Showing 1 - 5

Ronald L Tokar, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 299 W Tietan St, Walla Walla, WA 99362 Phone: 509-525-2100    Fax: 509-522-0313

Dr. Arthur W Giebel, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1610 Penny Ln, Walla Walla, WA 99362 Phone: 509-540-3937    Fax: 509-540-3938

Dr. Andrew S Edwards, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 299 W Tietan St, Walla Walla, WA 99362 Phone: 509-525-2100    Fax: 509-522-0313

Dr. Jamie M Coleman, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1610 Penny Ln, Walla Walla, WA 99362 Phone: 509-529-3160    Fax: 509-396-7015

Linda A Gunshefski, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 299 W Tietan St, Walla Walla, WA 99362 Phone: 509-525-2100    Fax: 509-522-0313

News Archive

COVID stalks Montana town already saddled with asbestos disease

Like thousands of people from Libby and Lincoln County in the far northwestern corner of Montana, the 61-year-old Fahland has scarred lungs after years of breathing in asbestos fibers from dust and soil contaminated by the town's now-defunct plant that produced vermiculite, a mineral used in insulation and gardening.

Cellular grafting procedure helps young patients with knee disorder get active

At 14 years old, Adam Vasser of Los Altos, Calif., was an active kid who loved baseball.

Hyperion Therapeutics enrolls first patient in HPN-100 phase III clinical trial for urea cycle disorders

Hyperion Therapeutics today announced that the first patient has been enrolled in its pivotal phase III clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate). The 4-week, multi-center, randomized, double-blind, cross-over study is designed to evaluate the non-inferiority of glycerol phenylbutyrate to BUPHENYL® (sodium phenylbutyrate) Tablets and Powder in adults with urea cycle disorders.

Study shows young patients are at highest risk of colorectal cancer progression, death

Younger patients with colorectal cancer that has spread to other parts of the body represent a high-risk group that is less likely to respond to treatment. Colorectal cancer in patients younger than 40 is more likely to grow despite treatment and young patients are at greater risk of death than people in other age groups.

Read more Medical News

› Verified 8 days ago